<DOC>
	<DOC>NCT01570517</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety and potential benefits of the interatrial septal defect (IASD) System in patients with heart failure with preserved ejection fraction.</brief_summary>
	<brief_title>Feasibility Trial of the DC Devices Interatrial Septal Device (IASD) System</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Clinical diagnosis of HFpEF Ejection Fraction of at least 45% Imaging and hemodynamic evidence of HFpEF History of exercise intolerance Symptomatic despite optimal medical management Signed study specific informed consent History of thromboembolic events Significant structural heart disease or coronary artery disease Contraindicated to study required medication Right ventricular dysfunction History of greater than mild restrictive or obstructive lung disease Life expectancy less than one year for noncardiovascular reasons Known or suspected allergy to implant material Fertile women</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>